Search - tctmd.com

Displaying 101 - 120 of 121

Sort: Relevancy | Date

News Conference News ACC 2014

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Jason Kahn

March 31, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Conference News ACC 2013

Studies Fail to Tame Controversy Over Off- vs. On-Pump CABG

March 11, 2013

News Conference News ACC 2013

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

L.A. McKeown

March 08, 2013

News Conference News ACC 2013

Novel Atherectomy System Helps Treat Severely Calcified Lesions

Jason Kahn

March 08, 2013

News Conference News ACC 2013

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

L.A. McKeown

March 08, 2013

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

Presentation ACC 2012

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Presenter: Gregg Stone

March 28, 2012

News Conference News ACC 2012

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Yael L. Maxwell

March 27, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

Presentation ACC 2012

Drug-Eluting Balloons: Novel Technology and Applications

Presenter: Sigmund Silber

March 26, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Conference News ACC 2012

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Jason Kahn

March 25, 2012

News Conference News ACC 2012

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

March 25, 2012

News Conference News ACC 2012

CPORT-E: PCI Outcomes Similar Regardless of On-Site Cardiac Surgery

March 25, 2012

News Conference News ACC 2012

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

L.A. McKeown

March 25, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

Advertisement

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Studies Fail to Tame Controversy Over Off- vs. On-Pump CABG

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

Novel Atherectomy System Helps Treat Severely Calcified Lesions

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

Drug-Eluting Balloons: Novel Technology and Applications

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

CPORT-E: PCI Outcomes Similar Regardless of On-Site Cardiac Surgery

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content